Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cyberonics Hits A Nerve: FDA Issues Firm Warning Letter For QSR Deficiencies

Jan 10 2005

Related Content

Cyberonics Resumes Bid For Depression Indication, Submits Two-Year Data

Sep 27 2004

Cyberonics NCP Patient Adverse Events To Be Reviewed In Meeting With FDA

Apr 16 2001

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window